Lansing, Mich. - In a move to reduce drug expenditures for someMedicaid patients, Michigan has published a restricted formulary involving40 categories of illness, including two dermatology classes.
Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated Melanoma
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
New Dermatology Social Comparison Scale Demonstrates Acceptable Psychometrics for Clinical and Research Applications
ReV Up Your Vitiligo Treatment Strategies
A Novel Approach to Distinguishing Scabies From Atopic Dermatitis
Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable